iX Biopharma Ltd. announced that on Jan, 9 2026 it allotted and issued 51,155 new ordinary shares following the exercise of warrants at an exercise price of 0.06 Singapore dollars per share.

The issuance lifts the company’s total share base to 958,101,805 from 958,050,650.

The newly issued shares rank pari passu with the existing shares and are expected to begin trading on the Singapore Exchange on or around Jan, 13 2026.

To date, 3,142,360 warrants, equivalent to 5.46% of all warrants previously issued, have been exercised. The remaining 54,367,119 warrants, each exercisable at 0.06 Singapore dollars, will expire on Jul, 18 2026.